Premium
P4‐418: A randomized, double‐blind, placebo‐controlled 16 week study of the H3 receptor antagonist GSK239512 in subjects with mild‐to‐moderate Alzheimer's disease (AD)
Author(s) -
Grove Richard,
Horrigan Joseph,
Harrington Conn,
Beresford Isabel,
Mahler Andreas
Publication year - 2011
Publication title -
alzheimer's and dementia
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 6.713
H-Index - 118
eISSN - 1552-5279
pISSN - 1552-5260
DOI - 10.1016/j.jalz.2011.09.114
Subject(s) - placebo , psychology , medicine , repeated measures design , clinical endpoint , randomized controlled trial , alternative medicine , pathology , statistics , mathematics
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom